Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

Pemetrexed-based chemotherapy regimens (pem regimens) are the standard first-line treatment option in patients with non-squamous non–small cell lung cancer (NSCLC). The objective of this systematic review was to assess the efficacy of pemetrexed in the context of epidermal growth factor receptor (EG...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, BaoHui, Yang, LuLu, Wang, Xin, Yao, LuanDi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905532/
https://www.ncbi.nlm.nih.gov/pubmed/29695919
http://dx.doi.org/10.2147/OTT.S157370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905532/
https://www.ncbi.nlm.nih.gov/pubmed/29695919
http://dx.doi.org/10.2147/OTT.S157370

Ejemplares similares